Don’t be a basic witch this year for Halloween because honestly you deserve better and no one wants to see you in a taco foam costume for the third year in a row. Transform into the “Hi, welcome to Chili’s” vine with our first-ever Halloween costume. Go to welcometochilis.com to get your hands on this Halloween treat while supplies last.
This one-of-a-kind Chili’s® Grill & Bar costume is sourced from tears of pure laughter, made with the finest cotton-polyester blend known to man and designed with a custom pattern you won’t find anywhere else. This Halloween, slip on your boxers and hold up that cardboard cell and get ready to welcome people to Chili’s all night long!
To view the multimedia release go to:
https://www.multivu.com/players/English/8246359-chilis-halloween-costume-of-2018/
Avon Products Inc. today officially announced a breakthrough anti-aging sun care collection — ANEW Solar Advance with RepairShield™ Technology. The research behind this revolutionary line was unveiled at the American Academy of Dermatology’s 69th annual meeting. The ANEW Solar Advance anti-aging sun care line not only provides superior protection against the sun’s damaging rays with photostable broad-spectrum UVA/UVB protection, but is also designed to repair skin cell sun damage.* Patented RepairShield Technology™ is designed to protect skin by stimulating its natural antioxidant defense system to fight free radicals and to repair by activating skin’s natural repair process.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/avon/42980/
Sutter Neuroscience Institute, a recognized Center of Excellence, and CBR (Cord Blood Registry), the world’s largest stem cell bank, are launching the first FDA- approved clinical trial to assess the use of a child’s own cord blood stem cells to treat select patients with autism. This first-of-its-kind placebo controlled study will evaluate the ability of an infusion of cord blood stem cells to help improve language and behavior. The study is in conjunction with the Sutter Institute for Medical Research.
To view Multimedia News Release, go to http://www.multivu.com/mnr/57707-cord-blood-registry-stem-cell-trials-child-autism
Daimler AG, Ford Motor Company and Nissan Motor Co., Ltd., have signed a unique three-way agreement to accelerate the commercialization of fuel cell electric vehicle (FCEV) technology.
The goal of the collaboration is to jointly develop a common fuel cell electric vehicle system while reducing investment costs associated with the engineering of the technology. Each company will invest equally towards the project. The strategy to maximize design commonality, leverage volume and derive efficiencies through economies of scale will help to launch the world’s first affordable, mass-market FCEVs as early as 2017.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58680-renault-nissan-daimler-ford-partnership
In recent years there has been a shift in the understanding of cancer. Immunotherapy with vaccines has been emerging as the most promising direction towards a decisive improvement of treatment outcomes.
The Dendritic Cell Vaccine has received FDA approval for prostate cancer and trials are now under way for a variety of other cancers. These vaccines are usually administered on their own.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64654-issels-integrative-immunotherapy-for-standard-therapy-resistant-cancers
As part of an ongoing commitment to support life sciences innovators and the development of integrated, cross-sector solutions to prevent, intercept and cure diseases, Johnson & Johnson today named cell biologist Yoshinori Ohsumi, Ph.D., of the Tokyo Institute of Technology the winner of the 2016 Dr. Paul Janssen Award for Biomedical Research for his pioneering discoveries concerning the molecular basis of autophagy.
Dr. Ohsumi was honored today during an event at the 2016 BIO International Convention in San Francisco. A video of his acceptance comments can be viewed here.
“Dr. Ohsumi’s curiosity led him to become the first person in the world to determine the molecular mechanism and regulation of autophagy, shedding light on one of the most basic functions of all living cells,” said Paul Stoffels, M.D., Chief Scientific Officer, Johnson & Johnson. “Dr. Ohsumi’s discoveries hold promise for better understanding, preventing and treating many diseases. It is with great pleasure that we celebrate his contributions, which remind us of the innovative spirit Dr. Paul brought to the lab every day.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7856351-2016-dr-paul-janssen-award-ohsumi/
